The unavailability of life-saving medicines has become a nightmare for patients in the absence of fall-back options, while the government has failed to follow their own pricing policy devised more than a year ago, said Pakistan Chemist and Druggist Association (PCDA) Secretary General Asim Jamil.
Jamil said that neither the stakeholders nor the general public is benefitting from the regulation of drugs, which is resulting in shortage and failure to sustain a viable business structure for the stakeholders.
Economist Syed Ali Hassan said, “Price controls are never a long-term or favourable solution.”
‘It reduces incentives for manufacturers to continue production of medicines as all other resources and materials used to manufacture keep on increasing,’’ he added.
Published in The Express Tribune, April 2nd, 2016.
Like Business on Facebook, follow @TribuneBiz on Twitter to stay informed and join in the conversation.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ